Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
NFL
U.S.
2024 Election
Local
World
Science
Technology
AI
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
GLP-1 weight-loss drugs might help protect kidneys
The potential health benefits of GLP-1 diabetes and weight loss meds keep piling up: New research shows they may also shield your kidneys from harm. In the largest study to date on the effects of the drugs on the kidneys, researchers found GLP-1s help the protect the organs in people with or without diabetes.
Millions more Americans might get access to GLP-1 drugs
Related: Crazy-expensive weight loss drugs may soon see a major change In other news, The Biden Administration is set to introduce a change that could impact more than 7 million people covered by Medicare and Medicaid.
5 GLP-1 marketing trends as brands jump on weight loss drug craze
As use of GLP-1 weight loss drugs including Wegovy and Ozempic increases, brands are introducing new offerings.
Study Finds GLP-1 Meds Can Also Help the Kidneys
GLP-1 medications like Ozempic and Wegovy are shielding the kidneys from harm, even as they help ease diabetes and obesity. Folks taking the meds have significantly lower odds for
Lancet Study Says GLP-1 Drugs Ozempic, Wegovy Can Be Beneficial For The Kidneys
A new study published in The Lancet Diabetes & Endocrinology found that GLP-1 drugs can also protect your kidneys from damage. This is the largest study which analysed the effects of the drugs on the kidneys of people with or without diabetes.
4h
The “Holiday Pause” For GLP-1s Is Quickly Approaching — but Is It Safe?
Takers of GLP-1 are reportedly going on a "holiday pause" to enjoy meal centric family celebrations. Here, an MD breaks down ...
1d
on MSN
Ozempic, Wegovy covered by Medicare and Medicaid under Biden admin proposal for anti-obesity GLP-1 drugs
The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have ...
STAT
1d
Inside the telehealth-fueled GLP-1 alternative market
The new class of GLP-1 weight loss drugs have been blockbusters since they arrived on the market a few years ago. These ...
News Medical on MSN
11h
GLP-1 receptor agonists reduce kidney failure risk and cardiovascular events
Researchers evaluate the effects of glucagon-like peptide-1 receptor agonists on kidney and cardiovascular outcomes.
2d
on MSN
West Virginia residents struggle to afford GLP-1 weight loss drugs after state ends subsidy program
In 2020, West Virginia launched a pilot program to subsidize GLP-1 drugs for public employees, but the program was shuttered ...
Medscape
18h
GLP-1 Labels Don’t Reflect Trial Exclusions
Clinicians are advised to screen patients for conditions that would have rendered them ineligible to participate in the ...
8d
This new supplement aims to support natural GLP-1 production and gut health
Inno Supps’ Trim Biome™ GLP-1 is designed to support the body’s natural production of GLP-1 through a unique blend of ...
WebMD
1d
White House Wants Medicare, Medicaid to Cover GLP-1 Drugs
In its announcement, the Biden administration called anti-obesity medicines “life-saving drugs,” noting that they can also ...
Medscape
1d
GLP-1 RA Drug Class Benefits People With SLE, Lupus Nephritis
The glucose-lowering and weight-reducing drug class appears to benefit the heart and kidneys in people with lupus and lupus nephritis, independently of glucose-lowering and weight loss.
Crain's Chicago Business
17h
With GLP-1s on the rise, bariatric surgeries and high margins fall
Strata Decision Technology data finds the number of bariatric surgeries in the Chicago area may have fallen by more than half ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Biden
Ozempic
Food and Drug Administration
receptor agonists
West Virginia
Feedback